Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuhuang Jiangze capsule is a Traditional Chinese Medicine (TCM) preparation indicated for the treatment of type 2 diabetes, particularly for patients presenting with Qi yin two deficiency heat syndrome. It is an NMPA-approved medicine in China, recognized for its unique ability to repair damaged islet tissue. The drug employs a multi-component, multi-target approach to promote endogenous insulin secretion, enhance glucose metabolism, reduce fat and protein breakdown, lower blood sugar and blood lipid levels, improve microcirculation, and mitigate diabetic complications. This innovative TCM aims to address the root causes of diabetes beyond mere blood sugar control.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuhuang Jiangze capsule.